ACI
CORT icon

AMP Capital Investors’s Corcept Therapeutics CORT Stock Holding History

AMP Capital Investors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-20,047
Closed -$315K – 1157
2018
Q2 		$315K Hold
20,047
– – ﹤0.01% 1065
2018
Q1 		$319K Buy
+20,047
New +$371K ﹤0.01% 1062
2017
Q4 		– Sell
-29,535
Closed -$570K – 1189
2017
Q3 		$570K Buy
+29,535
New +$440K ﹤0.01% 982

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AMP Capital Investors's CORT Position: Q3 2018 in Review

AMP Capital Investors sold out of Corcept Therapeutics (CORT) in Q3 2018, closing a stake of 20,047 shares — an estimated $315K sold.

AMP Capital Investors first reported a position in CORT in Q3 2017 and held it in 3 quarters. The position peaked at $570K in Q3 2017. 207 funds tracked by Wall St. Rank hold CORT as of Q3 2018.

  • AMP Capital Investors reported no remaining Corcept Therapeutics position as of Q3 2018 after selling out during the quarter.
  • AMP Capital Investors sold 20,047 Corcept Therapeutics shares in Q3 2018, an estimated $315K.
  • AMP Capital Investors first reported a position in Corcept Therapeutics in Q3 2017 and held it in 3 quarters.
  • AMP Capital Investors's Corcept Therapeutics position peaked at $570K in Q3 2017.
  • 207 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2018.

Based on AMP Capital Investors's 13F filing for Q3 2018, filed 13 Nov 2018.